Abstract
Background. A 5-year-old white girl with a history of hypothyroidism in infancy presented to the endocrinology clinic of a tertiary hospital. Her physical examination noted a stocky physique, broad chest, short neck and short digits. Two years later, skin examination revealed subcutaneous nodules and acanthosis nigricans.
Investigations. Measurement of levels of serum phosphate, parathyroid hormone, ionized calcium and insulin; measurement of peak growth hormone by the arginine–levodopa stimulation test; calculation of homeostasis model assessment of insulin resistance; assessment of bone age; DNA analysis of the GNAS gene.
Diagnosis. Pseudohypoparathyroidism type 1a in a patient with Albright hereditary osteodystrophy, characterized by hypocalcemia, hypothyroidism, growth-hormone deficiency and insulin resistance.
Management. The child continued to take levothyroxine 25 µg once daily, and at 5 years of age she was started on 40 mg/kg elemental calcium as calcium carbonate daily, and calcitriol (active vitamin D) 0.25 µg twice daily. Lifestyle modifications were also recommended for weight control. At 6 years and 4 months of age, treatment with growth hormone was initiated at a dose of 0.3 mg/kg weekly.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Levy, J. C. et al. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21, 2191–2192 (1998).
Murphy, M. J. et al. Distribution of adiponectin, leptin, and metabolic correlates of insulin resistance: a longitudinal study in British children; 1: prepuberty (EarlyBird 15). Clin. Chem. 54, 1298–1306 (2008).
Balagopal, P. et al. Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. J. Pediatr. 146, 342–348 (2005).
Keskin, M. et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115, e500–e503 (2005).
Greulich, W. W. & Pyle, S. I. (eds) Radiographic Atlas of Skeletal Development of the Hands and Wrists, 2nd edn (Stanford University Press, Stanford, 1959).
Sambrook, J. (ed.) Molecular Cloning: a Laboratory Manual. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989).
Germain-Lee, E. L. et al. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J. Clin. Endocrinol. Metab. 88, 4059–4069 (2003).
Weinstein, L. S. & Shenker, A. G. Protein mutations in human disease. Clin. Biochem. 26, 333–338 (1993).
Lietman, S. A. et al. Preimplantation genetic diagnosis for severe Albright hereditary osteodystrophy. J. Clin. Endocrinol. Metab. 93, 901–904 (2008).
Brickman, A. S. et al. Responses to glucagon infusion in pseudohypoparathyroidism. J. Clin. Endocrinol. Metab. 63, 1354–1360 (1986).
Weinstein, L. S. et al. Minireview: GNAS: normal and abnormal functions. Endocrinology 145, 5459–5464 (2004).
Long, D. N. et al. Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Gαs in the development of human obesity. J. Clin. Endocrinol. Metab. 92, 1073–1079 (2007).
Pohlenz, J. et al. A new heterozygous mutation (L338N) in the human Gsα (GNAS1) gene as a cause for congenital hypothyroidism in Albright's hereditary osteodystrophy. Eur. J. Endocrinol. 148, 463–468 (2003).
Chan, I. et al. Progressive osseous heteroplasia resulting from a new mutation in the GNAS1 gene. Clin. Exp. Dermatol. 29, 77–80 (2004).
Scott, D. C. & Hung, W. Pseudohypoparathyroidism type Ia and growth hormone deficiency in two siblings. J. Pediatr. Endocrinol. Metab. 8, 205–207 (1995).
Chen, Y. J. et al. Pseudohypoparathyroidism: report of seven cases. Acta Paediatr. Taiwan 46, 374–380 (2005).
de Wijn, E. M. & Steendijk, R. Growth and maturation in pseudo-hypoparathyroidism: a longitudinal study in 5 patients. Acta Endocrinol. (Copenh.) 101, 223–226 (1982).
Steinbach, H. L. & Young, D. A. The roentgen appearance of pseudohypoparathyroidism (PH) and pseudo-pseudohypoparathyroidism (PPH). Differentiation from other syndromes associated with short metacarpals, metatarsals, and phalanges. Am. J. Roentgenol. Radium Ther. Nucl. Med. 97, 49–66 (1966).
Kobayashi, T. et al. PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development 129, 2977–2986 (2002).
Tavella, S. et al. Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression. J. Bone Miner. Res. 19, 1678–1688 (2004).
van der Eerden, B. C. et al. Expression of Indian hedgehog, parathyroid hormone-related protein, and their receptors in the postnatal growth plate of the rat: evidence for a locally acting growth restraining feedback loop after birth. J. Bone Miner. Res. 15, 1045–1055 (2000).
Schuster, V. & Sandhage, K. Intracardiac calcifications in a case of pseudohypoparathyroidism type Ia (PHP-Ia). Pediatr. Cardiol. 13, 237–239 (1992).
Sakaguchi, H. et al. A case of Albright's hereditary osteodystrophy-like syndrome complicated by several endocrinopathies: normal Gsα gene and chromosome 2q37. J. Clin. Endocrinol. Metab. 83, 1563–1565 (1998).
Caprio, S. Insulin resistance in childhood obesity. J. Pediatr. Endocrinol. Metab. 15 (Suppl. 1), 487–492 (2002).
Bastard, J. P. et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17, 4–12 (2006).
Sasaka-Suzuki, N. et al. GH inhibition of glucose uptake in adipocytes occurs without affecting GLUT-4 translocation through an IRS-2PI 3-kinase-dependent pathway. J. Biol. Chem. 284, 6061–6070 (2009).
Meigs, J. B. et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N. Engl. J. Med. 359, 2208–2219 (2008).
Spiegel, A. M. et al. Deficiency of hormone receptor-adenylate cyclase coupling protein: basis for hormone resistance in pseudohypoparathyroidism. Am. J. Physiol. 243, E37–E42 (1982).
Balavoine, A. S. et al. Hypothyroidism in patients with pseudohypoparathyroidism type Ia: clinical evidence of resistance to TSH and TRH. Eur. J. Endocrinol. 159, 431–437 (2008).
Abraham, M. R. & Khadori, R. K. Pseudohypoparathyroidism. eMedicine [online], (2007).
Acknowledgements
Written consent for publication was obtained from the patient's mother. Charles P. Vega, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscape-accredited continuing medical education activity associated with this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Nwosu, B., Lee, M. Pseudohypoparathyroidism type 1a and insulin resistance in a child. Nat Rev Endocrinol 5, 345–350 (2009). https://doi.org/10.1038/nrendo.2009.81
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2009.81
This article is cited by
-
Explorative research on glucolipid metabolism and levels of adipokines in pseudohypoparathyroidism type 1 patients
Orphanet Journal of Rare Diseases (2023)
-
Parathyroid diseases and metabolic syndrome
Journal of Endocrinological Investigation (2023)
-
Pseudohypoparathyroidism, acrodysostosis, progressive osseous heteroplasia: different names for the same spectrum of diseases?
Endocrine (2021)
-
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
Nature Reviews Endocrinology (2018)
-
Energy expenditure in obese children with pseudohypoparathyroidism type 1a
International Journal of Obesity (2013)